MDMA is beginning Phase 3 trials for the treatment of PTSD.
Flagging that both MDMA & psilocybin have received “breakthrough therapy” designation from the FDA.
(MDMA through the work of MAPS; psilocybin through the work of Compass Pathways.)
As an aside: I just came across this disturbing critique of Compass Pathways. Sounds like they might not be as public-spirited as I’d initially assumed. But I haven’t looked into it in detail. https://qz.com/1454785/a-millionaire-couple-is-threatening-to-create-a-magic-mushroom-monopoly/
Yeah, people have a variety of opinions about Compass.
Compass and the Usona Institute are independently pursuing FDA rescheduling of psilocybin. Compass is likely to have their product rescheduled first.
I think it’s good that Usona is working through the FDA process, because they’re a nonprofit and thus have a different incentive-set than Compass.
Just saw that Good Ventures continues to support Usona’s research (separate from their involvement with Open Phil).
Interesting, thanks.
Flagging that both MDMA & psilocybin have received “breakthrough therapy” designation from the FDA.
(MDMA through the work of MAPS; psilocybin through the work of Compass Pathways.)
As an aside: I just came across this disturbing critique of Compass Pathways. Sounds like they might not be as public-spirited as I’d initially assumed. But I haven’t looked into it in detail. https://qz.com/1454785/a-millionaire-couple-is-threatening-to-create-a-magic-mushroom-monopoly/
Yeah, people have a variety of opinions about Compass.
Compass and the Usona Institute are independently pursuing FDA rescheduling of psilocybin. Compass is likely to have their product rescheduled first.
I think it’s good that Usona is working through the FDA process, because they’re a nonprofit and thus have a different incentive-set than Compass.
Just saw that Good Ventures continues to support Usona’s research (separate from their involvement with Open Phil).
Interesting, thanks.